Selected NIAID Science News Highlights of 2019

In 2019, scientists at NIAID and NIAID-funded institutions continued to make progress in understanding, preventing and treating allergic, immunologic and infectious diseases. This year saw advances in treating Ebola virus disease, developing gene therapy for a rare immunologic disorder, and understanding the causes of acute flaccid myelitis. Other work accelerated progress toward development of a universal flu vaccine, enhanced knowledge of organ transplantation among people with HIV, and provided new tools for studying human prion diseases. In addition, NIAID made strides toward ending the HIV epidemic in the United States and preventing tuberculosis, the leading infectious cause of death worldwide. 

Ten selected science news highlights from 2019 are summarized below. All demonstrate how public investment in biomedical research drives scientific progress and benefits human health. 

Content last reviewed on